The rapidly changing health care landscape in the United States is witnessing a transition from a volume-based to a value-based reimbursement structure. In the process, patient care is also changing.
Â
What steps are biopharmaceutical companies, insurers, and providers taking to create a more value-driven health care system? Is there a role that policymakers can or should play to ensure that this approach improves outcomes and what are the implications for patients?
Â
The Hill will convene policymakers, health industry representatives, and patient advocates for a conversation about the impact of outcomes-based care.Â
- Â Liz Fowler, Vice President, Global Health Policy, Johnson & Johnson
- Â Patrick Geraghty, CEO, GuideWell and Florida Blue
- Â Pamela Sutton-Wallace, CEO, University of Virginia Medical Center
- Â Cynthia Zagieboylo, President and CEO, National Multiple Sclerosis Society
Moderated by Kim Dixon, Policy Editor, The Hill
For directions and parking details, click here
